<VariationArchive VariationID="419126" VariationName="NM_001243279.3(ACSF3):c.1446_1447del (p.Tyr482_Lys483delinsTer)" VariationType="Deletion" Accession="VCV000419126" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-17" DateCreated="2017-04-27" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="409783" VariationID="419126">
      <GeneList>
        <Gene Symbol="ACSF3" FullName="acyl-CoA synthetase family member 3" GeneID="197322" HGNC_ID="HGNC:27288" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89093852" stop="89156233" display_start="89093852" display_stop="89156233" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89160216" stop="89222170" display_start="89160216" display_stop="89222170" Strand="+" />
          </Location>
          <OMIM>614245</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001243279.3(ACSF3):c.1446_1447del (p.Tyr482_Lys483delinsTer)</Name>
      <CanonicalSPDI>NC_000016.10:89145344:ACA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89145345" stop="89145346" display_start="89145345" display_stop="89145346" variantLength="2" positionVCF="89145344" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89211753" stop="89211754" display_start="89211753" display_stop="89211754" variantLength="2" positionVCF="89211752" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.89145346_89145347del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.89145346_89145347del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.89211754_89211755del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.89211754_89211755del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031961.1" sequenceAccession="NG_031961" sequenceVersion="1" change="g.56538_56539del">
            <Expression>NG_031961.1:g.56538_56539del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127214.4" sequenceAccession="NM_001127214" sequenceVersion="4" change="c.1446_1447del">
            <Expression>NM_001127214.4:c.1446_1447del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120686.1" sequenceAccession="NP_001120686" sequenceVersion="1" change="p.Tyr482_Lys483delinsTer">
            <Expression>NP_001120686.1:p.Tyr482_Lys483delinsTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001243279.3" sequenceAccession="NM_001243279" sequenceVersion="3" change="c.1446_1447del" MANESelect="true">
            <Expression>NM_001243279.3:c.1446_1447del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001230208.1" sequenceAccession="NP_001230208" sequenceVersion="1" change="p.Tyr482_Lys483delinsTer">
            <Expression>NP_001230208.1:p.Tyr482_Lys483delinsTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001284316.2" sequenceAccession="NM_001284316" sequenceVersion="2" change="c.651_652del">
            <Expression>NM_001284316.2:c.651_652del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001271245.1" sequenceAccession="NP_001271245" sequenceVersion="1" change="p.Tyr217_Lys218delinsTer">
            <Expression>NP_001271245.1:p.Tyr217_Lys218delinsTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_174917.5" sequenceAccession="NM_174917" sequenceVersion="5" change="c.1446_1447del">
            <Expression>NM_174917.5:c.1446_1447del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_777577.2" sequenceAccession="NP_777577" sequenceVersion="2" change="p.Tyr482_Lys483delinsTer">
            <Expression>NP_777577.2:p.Tyr482_Lys483delinsTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_045667.2" sequenceAccession="NR_045667" sequenceVersion="2" change="n.572_573del">
            <Expression>NR_045667.2:n.572_573del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_104293.2" sequenceAccession="NR_104293" sequenceVersion="2" change="n.1837_1838del">
            <Expression>NR_104293.2:n.1837_1838del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147928.2" sequenceAccession="NR_147928" sequenceVersion="2" change="n.1881_1882del">
            <Expression>NR_147928.2:n.1881_1882del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147929.2" sequenceAccession="NR_147929" sequenceVersion="2" change="n.1635_1636del">
            <Expression>NR_147929.2:n.1635_1636del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_174917.5" sequenceAccession="NM_174917" sequenceVersion="5" change="c.1446_1447delCA">
            <Expression>NM_174917.5:c.1446_1447delCA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16620296" DB="ClinGen" />
        <XRef Type="rs" ID="1064793662" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001243279.3(ACSF3):c.1446_1447del (p.Tyr482_Lys483delinsTer) AND not provided" Accession="RCV000480293" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-05-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001243279.3(ACSF3):c.1446_1447del (p.Tyr482_Lys483delinsTer) AND Methylmalonic acidemia" Accession="RCV001274023" Version="1">
        <ClassifiedConditionList TraitSetID="9017">
          <ClassifiedCondition DB="MedGen" ID="C0268583">Methylmalonic acidemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001243279.3(ACSF3):c.1446_1447del (p.Tyr482_Lys483delinsTer) AND Combined malonic and methylmalonic acidemia" Accession="RCV001383441" Version="9">
        <ClassifiedConditionList TraitSetID="7620">
          <ClassifiedCondition DB="MedGen" ID="C3280314">Combined malonic and methylmalonic acidemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-31" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-31" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-04-27" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21841779</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26827111</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30041674</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7620" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16574" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Combined malonic and methylmalonic aciduria</ElementValue>
                <XRef ID="Combined+malonic+and+methylmalonic+aciduria/8011" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Combined malonic and methylmalonic acidemia</ElementValue>
                <XRef ID="MONDO:0013661" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMAMMA</ElementValue>
                <XRef Type="MIM" ID="614265" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10818" />
                <XRef ID="10818" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="289504" DB="Orphanet" />
              <XRef ID="C3280314" DB="MedGen" />
              <XRef ID="MONDO:0013661" DB="MONDO" />
              <XRef Type="MIM" ID="614265" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9017" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6374" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated Methylmalonic Acidemia</ElementValue>
                <XRef ID="C537358" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Methylmalonic acidemia</ElementValue>
                <XRef ID="Methylmalonic+acidemia/4713" DB="Genetic Alliance" />
                <XRef ID="HP:0002912" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002012" DB="MONDO" />
                <XRef ID="42393006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7033" />
                <XRef ID="7033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">For this GeneReview, the term "isolated methylmalonic acidemia" refers to a group of inborn errors of metabolism associated with elevated methylmalonic acid (MMA) concentration in the blood and urine that result from the failure to isomerize (convert) methylmalonyl-coenzyme A (CoA) into succinyl-CoA during propionyl-CoA metabolism in the mitochondrial matrix, without hyperhomocysteinemia or homocystinuria, hypomethioninemia, or variations in other metabolites, such as malonic acid. Isolated MMA is caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (mut0 enzymatic subtype or mut– enzymatic subtype, respectively), a defect in the transport or synthesis of its cofactor, 5-deoxy-adenosyl-cobalamin (cblA, cblB, or cblD-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. Prior to the advent of newborn screening, common phenotypes included: Infantile/non-B12-responsive form (mut0 enzymatic subtype, cblB), the most common phenotype, associated with infantile-onset lethargy, tachypnea, hypothermia, vomiting, and dehydration on initiation of protein-containing feeds. Without appropriate treatment, the infantile/non-B12-responsive phenotype could rapidly progress to coma due to hyperammonemic encephalopathy. Partially deficient or B12-responsive phenotypes (mut– enzymatic subtype, cblA, cblB [rare], cblD-MMA), in which symptoms occur in the first few months or years of life and are characterized by feeding problems, failure to thrive, hypotonia, and developmental delay marked by episodes of metabolic decompensation. Methylmalonyl-CoA epimerase deficiency, in which findings range from complete absence of symptoms to severe metabolic acidosis. Affected individuals can also develop ataxia, dysarthria, hypotonia, mild spastic paraparesis, and seizures. In those individuals diagnosed by newborn screening and treated from an early age, there appears to be decreased early mortality, less severe symptoms at diagnosis, favorable short-term neurodevelopmental outcome, and lower incidence of movement disorders and irreversible cerebral damage. However, secondary complications may still occur and can include intellectual disability, tubulointerstitial nephritis with progressive impairment of renal function, "metabolic stroke" (bilateral lacunar infarction of the basal ganglia during acute metabolic decompensation), pancreatitis, growth failure, functional immune impairment, bone marrow failure, optic nerve atrophy, arrhythmias and/or cardiomyopathy (dilated or hypertrophic), liver steatosis/fibrosis/cancer, and renal cancer.</Attribute>
                <XRef ID="NBK1231" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301409</ID>
                <ID Source="BookShelf">NBK1231</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <XRef ID="C0268583" DB="MedGen" />
              <XRef ID="C537358" DB="MeSH" />
              <XRef ID="MONDO:0002012" DB="MONDO" />
              <XRef Type="primary" ID="HP:0002912" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003123" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008295" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1101822" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:427978|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000566715" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1446_1447delCA deletion in the ACSF3 gene causes the replacement of the normal Tyrosine codon atposition 482 with a Stop codon, denoted p.Tyr482Ter. This variant is predicted to cause loss of normalprotein function either through protein truncation or nonsense-mediated mRNA decay. Although thisdeletion has not been previously reported to our knowledge, it is expected to be a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACSF3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_174917.3:c.1446_1447delCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2872982" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_174917.5:c.1446_1447delCA|Methylmalonic acidemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001457707" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_174917.5:c.1446_1447delCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Methylmalonic acidemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5461794" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_174917.5:c.1446_1447del|OMIM:614265" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002813953" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_174917.5:c.1446_1447del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614265" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108215" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="5897513|MedGen:C3280314" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582589" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21841779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26827111</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30041674</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr482*) in the ACSF3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACSF3 are known to be pathogenic (PMID: 21841779, 26827111). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with combined malonic and methylmalonic aciduria (PMID: 30041674). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 419126). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACSF3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.89211753_89211754del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280314" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865358" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001127214.4:c.1446_1447del|OMIM:614265" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004214811" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127214.4:c.1446_1447del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614265" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1101822" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2872982" TraitType="Disease" MappingType="Name" MappingValue="Methylmalonic acidemia" MappingRef="Preferred">
        <MedGen CUI="C0268583" Name="Methylmalonic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3108215" TraitType="Disease" MappingType="XRef" MappingValue="C3280314" MappingRef="MedGen">
        <MedGen CUI="C3280314" Name="Combined malonic and methylmalonic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865358" TraitType="Disease" MappingType="XRef" MappingValue="614265" MappingRef="OMIM">
        <MedGen CUI="C3280314" Name="Combined malonic and methylmalonic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461794" TraitType="Disease" MappingType="XRef" MappingValue="614265" MappingRef="OMIM">
        <MedGen CUI="C3280314" Name="Combined malonic and methylmalonic acidemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

